April 30, 2012
Two genomic regions have been identified that are associated with normal-pressure glaucoma (NPG) and optic nerve disease in exfoliation-syndrome glaucoma (ESG), possibly through the transforming growth factor beta (TGF-beta) signaling pathway.
March 13, 2012
Although the overall impact of routine glaucoma screening of middle-aged African-Americans may be modest, it would likely reduce the lifetime prevalence of glaucoma and glaucoma-related visual impairment and blindness.
February 17, 2012
Men with erectile dysfunction (ED) are almost three times more likely to have been previously diagnosed with glaucoma.
February 15, 2012
Generic topical prostaglandin analogs (PGAs) and treatment with laser trabeculoplasty (LTP) are both cost-effective for treatment of newly diagnosed mild open-angle glaucoma, with PGAs providing better quality of life relative to LTP.
September 26, 2011
Clermont Pharmaceuticals announced positive results from its Phase 3 study of non-preserved latanoprost for the treatment of glaucoma.